Disease-activity & biomarker data
Data collection built around composite indices such as ACR20/50/70, DAS28, and PASI, with structured pipelines for cytokine and autoantibody biomarker panels alongside joint and skin assessments.
Why immunology sponsors choose us
Built for composite indices and biosimilar comparability
Three ways an integrated Biometrics and Clinical Operations model changes how an immunology program runs.
Biostatistics for biologics & biosimilars
Statistical support for originator and biosimilar programs, including equivalence and non-inferiority designs, immunogenicity analysis, and long-term extension safety follow-up.
Anti-drug antibody sampling coordination
Site-level sample timing and central lab coordination built to keep immunogenicity sampling on schedule across every dosing visit.
Common questions
Before you scope an immunology study
Running an immunology or biosimilar program?
Tell us your indication, phase, and comparability requirements — we'll map a Biometrics and Clinical Operations model built for composite endpoints.